The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Abstract Details
|
Activity Number:
|
533
|
|
Type:
|
Roundtables
|
|
Date/Time:
|
Wednesday, August 3, 2011 : 12:30 PM to 1:50 PM
|
|
Sponsor:
|
Section for Statistical Programmers and Analysts
|
| Abstract - #302254 |
|
Title:
|
Unleashing the Power of the Scientific Programmer in the Pharmaceutical Industry
|
|
Author(s):
|
Amy E. Gillespie*+ and Lori Mixson
|
|
Companies:
|
Merck & Co., Inc. and Merck & Co., Inc.
|
|
Address:
|
P.O. Box 1000, Upper Gwynedd, PA, 19454-2505,
|
|
Keywords:
|
statistical programming ;
early phase ;
epidemiology ;
economics ;
SAS ;
R
|
|
Abstract:
|
Statistical programmers in the pharmaceutical industry primarily focus their support to phase II and III clinical development research, utilizing SAS to develop analysis and submission ready datasets, tables, and figures. Our roundtable discussion will challenge this traditional viewpoint as we debate strategic ways of utilizing the skills of statistical programming professionals in other areas of drug development. Topics for discussion will include statistical programming in support of early phase development, epidemiology, health economics, challenges of working with novel data types and requirements to preprocess, filter, and manipulate data prior to analyses, development of standards for areas that require flexibility and exploratory environments, and software usage including SAS, R, Matlab, and Splus.
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2011 program
|
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.